XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Oct. 31, 2022   979,869,000      
Balance at beginning of period at Oct. 31, 2022 $ (3,025) $ 10 $ 1,172 $ (4,492) $ 285
Increase (Decrease) in Stockholders' Equity          
Net earnings 469     469  
Other comprehensive income (loss), net of taxes (741)       (741)
Comprehensive income (loss) (272)        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,844,000      
Issuance of common stock in connection with employee stock plans and other (79)   (79)    
Repurchases of common stock (in shares)   (3,624,000)      
Repurchases of common stock (Note 10) (100)   (4) (96)  
Cash dividends (518)     (518)  
Stock-based compensation expense 167   167    
Balance (in shares) at Jan. 31, 2023   985,089,000      
Balance at end of period at Jan. 31, 2023 (3,827) $ 10 1,256 (4,637) (456)
Balance (in shares) at Oct. 31, 2022   979,869,000      
Balance at beginning of period at Oct. 31, 2022 (3,025) $ 10 1,172 (4,492) 285
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,523        
Other comprehensive income (loss), net of taxes (653)        
Comprehensive income (loss) $ 870        
Repurchases of common stock (in shares) (3,600,000)        
Balance (in shares) at Apr. 30, 2023   985,876,000      
Balance at end of period at Apr. 30, 2023 $ (2,593) $ 10 1,344 (3,579) (368)
Balance (in shares) at Jan. 31, 2023   985,089,000      
Balance at beginning of period at Jan. 31, 2023 (3,827) $ 10 1,256 (4,637) (456)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,054     1,054  
Other comprehensive income (loss), net of taxes 88       88
Comprehensive income (loss) 1,142        
Issuance of common stock in connection with employee stock plans and other (in shares)   787,000      
Issuance of common stock in connection with employee stock plans and other $ (7)   (7)    
Repurchases of common stock (in shares) 0        
Cash dividends $ 4     4  
Stock-based compensation expense 95   95    
Balance (in shares) at Apr. 30, 2023   985,876,000      
Balance at end of period at Apr. 30, 2023 $ (2,593) $ 10 1,344 (3,579) (368)
Balance (in shares) at Oct. 31, 2023 989,000,000 988,782,000      
Balance at beginning of period at Oct. 31, 2023 $ (1,069) $ 10 1,505 (2,361) (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 622     622  
Other comprehensive income (loss), net of taxes (235)       (235)
Comprehensive income (loss) 387        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,677,000      
Issuance of common stock in connection with employee stock plans and other (76)   (76)    
Repurchases of common stock (in shares)   (17,062,000)      
Repurchases of common stock (Note 10) (514)   (27) (487)  
Cash dividends (545)     (545)  
Stock-based compensation expense 177   177    
Balance (in shares) at Jan. 31, 2024   980,397,000      
Balance at end of period at Jan. 31, 2024 $ (1,640) $ 10 1,579 (2,771) (458)
Balance (in shares) at Oct. 31, 2023 989,000,000 988,782,000      
Balance at beginning of period at Oct. 31, 2023 $ (1,069) $ 10 1,505 (2,361) (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,229        
Other comprehensive income (loss), net of taxes (109)        
Comprehensive income (loss) $ 1,120        
Repurchases of common stock (in shares) (20,500,000)        
Balance (in shares) at Apr. 30, 2024 978,000,000 977,507,000      
Balance at end of period at Apr. 30, 2024 $ (916) $ 10 1,663 (2,257) (332)
Balance (in shares) at Jan. 31, 2024   980,397,000      
Balance at beginning of period at Jan. 31, 2024 (1,640) $ 10 1,579 (2,771) (458)
Increase (Decrease) in Stockholders' Equity          
Net earnings 607     607  
Other comprehensive income (loss), net of taxes 126       126
Comprehensive income (loss) 733        
Issuance of common stock in connection with employee stock plans and other (in shares)   584,000      
Issuance of common stock in connection with employee stock plans and other $ (4)   (4)    
Repurchases of common stock (in shares) (3,500,000) (3,474,000)      
Repurchases of common stock (Note 10) $ (99)   (6) (93)  
Stock-based compensation expense $ 94   94    
Balance (in shares) at Apr. 30, 2024 978,000,000 977,507,000      
Balance at end of period at Apr. 30, 2024 $ (916) $ 10 $ 1,663 $ (2,257) $ (332)